belfasttelegraph Thursday, 23 October, 2014

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

Search news from around the web

  1. Ligand Pharmaceuticals (NASDAQ:LGND) Director John W. Kozarich purchased 2,000 shares of Ligand Pharmaceuticals stock on the open market in a transaction dated Wednesday, October 15th. The stock was ... FULL ARTICLE AT American Banking News

  2. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) and Inovio Pharmaceuticals Inc (NASDAQ:INO) are two stocks from the pharma space that have recently seen insiders buying shares in large quantities. Tejon Ranch ... FULL ARTICLE AT Insider Monkey

  1. Ligand Pharmaceuticals (NASDAQ:LGND) shares were up 6.9% during mid-day trading on Friday after an insider bought additional shares in the company, Analyst RN reports. The company traded as ... FULL ARTICLE AT American Banking News

  2. Ligand Pharmaceuticals (NASDAQ:LGND) Director Jason Aryeh purchased 11,000 shares of Ligand Pharmaceuticals stock in a transaction dated Thursday, October 9th. The shares were purchased at an average price ... FULL ARTICLE AT American Banking News

  3. Ligand Pharmaceuticals Incorporated (LGND) is expecting its third quarter 2014 adjusted earnings per share to be between 33 and 37 cents per share. FULL ARTICLE AT Zacks Investment Research

  1. Ligand Pharmaceuticals (NASDAQ:LGND)‘s stock had its “buy” rating reaffirmed by analysts at ING Group in a research report issued to clients and investors on Wednesday. Ligand Pharmaceuticals (NASDAQ ... FULL ARTICLE AT American Banking News

  2. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) updated its third quarter earnings guidance on Wednesday. The company provided EPS guidance of $0.33-0.37 for the period, compared to the Thomson Reuters ... FULL ARTICLE AT American Banking News

  3. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) updated its FY14 earnings guidance on Wednesday. The company provided EPS guidance of $1.50-1.55 for the period, compared to the Thomson Reuters consensus ... FULL ARTICLE AT American Banking News

  4. Ligand Pharmaceuticals (NASDAQ:LGND) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a report released on Tuesday. The firm currently has a $54.00 price ... FULL ARTICLE AT American Banking News

About this topic

Wikipedia

Ligand Pharmaceuticals Incorporated (Ligand), incorporated in 1987, is an early-stage biotech company that focuses on discovering and developing new drugs that address medical needs in the areas of thrombocytopenia, cancer, hepatitis C, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand has formed research and development collaborations for its products with numerous... Full Article At Wikipedia.org

Timeline of coverage

  1. Click to see all coverage from 2014-09-08
    2014-09-08
  2. Click to see all coverage from 2014-09-09
    2014-09-09
  3. Click to see all coverage from 2014-09-10
    2014-09-10
  4. Click to see all coverage from 2014-09-11
    2014-09-11
  5. Click to see all coverage from 2014-09-12
    2014-09-12
  6. Click to see all coverage from 2014-09-13
    2014-09-13
  7. Click to see all coverage from 2014-09-14
    2014-09-14
  8. Click to see all coverage from 2014-09-15
    2014-09-15
  9. Click to see all coverage from 2014-09-16
    2014-09-16
  10. Click to see all coverage from 2014-09-17
    2014-09-17
  11. Click to see all coverage from 2014-09-18
    2014-09-18
  12. Click to see all coverage from 2014-09-19
    2014-09-19
  13. Click to see all coverage from 2014-09-20
    2014-09-20
  14. Click to see all coverage from 2014-09-21
    2014-09-21
  15. Click to see all coverage from 2014-09-22
    2014-09-22
  16. Click to see all coverage from 2014-09-23
    2014-09-23
  17. Click to see all coverage from 2014-09-24
    2014-09-24
  18. Click to see all coverage from 2014-09-25
    2014-09-25
  19. Click to see all coverage from 2014-09-26
    2014-09-26
  20. Click to see all coverage from 2014-09-27
    2014-09-27
  21. Click to see all coverage from 2014-09-28
    2014-09-28
  22. Click to see all coverage from 2014-09-29
    2014-09-29
  23. Click to see all coverage from 2014-09-30
    2014-09-30
  24. Click to see all coverage from 2014-10-01
    2014-10-01
  25. Click to see all coverage from 2014-10-02
    2014-10-02
  26. Click to see all coverage from 2014-10-03
    2014-10-03
  27. Click to see all coverage from 2014-10-04
    2014-10-04
  28. Click to see all coverage from 2014-10-05
    2014-10-05
  29. Click to see all coverage from 2014-10-06
    2014-10-06
  30. Click to see all coverage from 2014-10-07
    2014-10-07
  31. Click to see all coverage from 2014-10-08
    2014-10-08
  32. Click to see all coverage from 2014-10-09
    2014-10-09
  33. Click to see all coverage from 2014-10-10
    2014-10-10
  34. Click to see all coverage from 2014-10-11
    2014-10-11
  35. Click to see all coverage from 2014-10-12
    2014-10-12
  36. Click to see all coverage from 2014-10-13
    2014-10-13
  37. Click to see all coverage from 2014-10-14
    2014-10-14
  38. Click to see all coverage from 2014-10-15
    2014-10-15
  39. Click to see all coverage from 2014-10-16
    2014-10-16
  40. Click to see all coverage from 2014-10-17
    2014-10-17
  41. Click to see all coverage from 2014-10-18
    2014-10-18
  42. Click to see all coverage from 2014-10-19
    2014-10-19
  43. Click to see all coverage from 2014-10-20
    2014-10-20
  44. Click to see all coverage from 2014-10-21
    2014-10-21
  45. Click to see all coverage from 2014-10-22
    2014-10-22
  46. Click to see all coverage from 2014-10-23
    2014-10-23

Login

Login to make editorial changes to the current page.

Login Cancel

Close